# Minimal Criteria to Screen for Wilson Disease: A Delphi Consensus in the United States

**Authors:** Jeff M. Bronstein, Regino P. Gonzalez-Peralta, Matthew Lorincz, Valentina Medici, Sergio Diaz-Mendoza, Krystallia Pantiri

PMC · DOI: 10.1155/ijh/5525442 · International Journal of Hepatology · 2025-11-01

## TL;DR

This study establishes minimal criteria for screening and diagnosing Wilson disease in U.S. clinical settings through expert consensus.

## Contribution

The paper provides a Delphi consensus-based framework for diagnosing Wilson disease in gastroenterology and neurology.

## Key findings

- Consensus was reached on 94 out of 126 statements regarding diagnostic criteria for Wilson disease.
- Noninvasive tests should precede invasive ones, and absence of KF rings does not exclude WD diagnosis.
- Multidisciplinary collaboration is emphasized for accurate diagnosis and management of Wilson disease.

## Abstract

The objective was to develop consensus on minimal screening criteria for Wilson disease (WD) diagnosis in US gastroenterology and neurology settings for implementation in clinical practice to support the timely diagnosis of WD.

A modified Delphi panel with three rounds was conducted. The first round survey was developed with input from a steering committee of four clinical experts in WD who set the analysis rules (consensus: ≥ 80%). Other US gastroenterologists/hepatologists or neurologists with experience treating WD were recruited using purposive sampling, and 32 were invited to participate.

Eleven panelists completed the three rounds. Consensus was reached for 94/126 (74.6%) statements. All panelists agreed that hepatomegaly, splenomegaly, or stigmata of liver disease are suggestive of WD in patients with a neuropsychiatric manifestation; a neurologic exam, 24-h urine copper, ceruloplasmin, and Kayser–Fleischer (KF) ring examination should be performed; and liver biopsy and liver copper determination can be a useful final stage to confirm WD diagnosis. Panelists agreed that noninvasive testing should be performed prior to invasive testing and that the absence of KF rings does not exclude a diagnosis of WD. Panelists agreed that it is important to collaborate in a multidisciplinary team.

This study identified minimal criteria to raise suspicion of WD, minimal tests to confirm or rule out a WD diagnosis, and areas with poor consensus to be explored in future research. These results can complement clinical practice guidance and support cross-specialty collaboration.

## Linked entities

- **Diseases:** Wilson disease (MONDO:0010200)

## Full-text entities

- **Genes:** CP (ceruloplasmin) [NCBI Gene 1356] {aka AB073614, CP-2}
- **Diseases:** splenomegaly (MESH:D013163), neuropsychiatric (MESH:C000631768), WD (MESH:D006527), hepatomegaly (MESH:D006529), liver disease (MESH:D008107)
- **Chemicals:** copper (MESH:D003300)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12596148/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12596148/full.md

## References

29 references — full list in the complete paper: https://tomesphere.com/paper/PMC12596148/full.md

---
Source: https://tomesphere.com/paper/PMC12596148